HIF1A and neoplasm: This upregulation of HIF1-α reveals that surviving normoxic tumor cells can accumulate HIF-1α, promoting VEGF secretion after doxorubicin treatment and their neo-angiogenesis, which could serve as a survival mechanism (Fig. 8).